Front. Oncol.
Frontiers in Oncology
Front. Oncol.
2234-943X
Frontiers Media S.A.
10.3389/fonc.2020.636664
Oncology
Retraction
Retraction: Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment
Frontiers Editorial Office
*
Approved by: Giuseppe Giaccone, Cornell University, United States
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology
23
12
2020
2020
10
636664
01
12
2020
01
12
2020
Copyright © 2020 Frontiers Editorial Office
2020
Frontiers Editorial Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Retraction of the Original Research Article Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment By Pei X, Zheng D, She S, Fang Z, Zhang S, Hu H, Xu K and Wang Y (2019). Front. Oncol. 9:724. doi: 10.3389/fonc.2019.00724
Following publication, concerns were raised regarding the duplication of the data presented in panels B and C of Figure 7 (Frontiers in Oncology, August 2019) and in panels A and B of Figure 7 in one of the author’s previous publications (J. Immunol. 2014 Feb 15;192(4):1878-86. doi: 10.4049/jimmunol.1300758). The authors failed to provide a satisfactory explanation.
This retraction was approved by the Chief Editors of Frontiers in Oncology.
The authors disagree with the retraction.